Medis Technologies Announces Successful Completion of Power Pack Engineering Test Program by Underwriter Laboratories

to carry out our planned program for additional lines.

"We will have the opportunity at The Consumer Electronic Show (CES) in Las Vegas, Nevada, that runs from January 8th to 11th, to meet with many customers and potential customers. We will have a booth in the Innovations Center demonstrating our Power Pack and other capabilities of our technology. We look forward to these meetings with considerable anticipation."

Medis Technologies' primary focus is on direct liquid fuel cell technology. Its business strategy is to sell its products to end users through retail outlets, service providers and to the military and other markets. Medis has also developed the CellScan with many potential applications relating to disease diagnostics and chemo sensitivity. Additionally, Medis' product pipeline includes other technologies, in varying stages of development.

This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called "forward-looking statements" by words such as "may," "will," "should," "expects," "plans," "targets," "believes," "anticipates," "estimates," "predicts," "potential," or "continue" or the negative of those words and other comparable words. These forward-looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.

This press release is available on Medis' web site at www.medistechnologies.com.

CONTACT: Medis Technologies Ltd. Robert K. Lifton Chairman & CEO (212) 935-8484

-OR-

INVESTOR RELATIONS COUNSEL: The Equity Group Inc. Adam Prior (212) 836-9606 Devin Sullivan (212) 836-9608

SOURCE:  Medis Technologies Ltd.

Author:  

Email:    

Topic:    

Content: